Top compounds associated with response to LRRD1


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.0028 0.9
mRNA BRD-K11533227 CTRPv2 pan-cancer AAC 0.003 0.9
mRNA CD-1530 CTRPv2 pan-cancer AAC 0.003 0.9
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.0027 0.9
mRNA Tamoxifen CTRPv2 pan-cancer AAC 0.0028 0.9
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.0027 0.9
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0026 0.9
mRNA AA-COCF3 CTRPv2 pan-cancer AAC -0.0025 0.9
mRNA paclitaxel UHNBreast pan-cancer AAC -0.021 0.9
mRNA CIL55A CTRPv2 pan-cancer AAC 0.0034 0.9
Download CSV